Sotera Health Company
SHCNASDAQHealthcare● Active
$15.86
+$0.24(+1.54%)
Market Cap$4.5B
P/E Ratio—
52W High$19.85
52W Low$10.795
Sotera Health Company (SHC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SHC · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 5, 2026EPS Actual
$0.18
Est. $0.17 · +5.9%
Revenue
$0.28B
Est. $0.27B · +3.4%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 5, 2026
After Market Close
▲ Beat EPS▲ Beat Revenue🔥 6-Quarter EPS Beat Streak
SHC reports quarterly as a NASDAQ-listed Medical - Diagnostics & Research company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 6, 2026 | $0.24 | — | — | — | $0.31B | — |
| ▲ Q2 FY2026 | May 5, 2026 | $0.17 | $0.18 | +5.9% | $0.28B | $0.27B | +3.4% |
| ▲ Q1 FY2026 | Feb 24, 2026 | $0.24 | $0.26 | +8.3% | $0.30B | $0.30B | +1.3% |
| ▲ Q4 FY2025 | Nov 4, 2025 | $0.22 | $0.26 | +18.2% | $0.31B | $0.30B | +3.9% |
| ▲ Q3 FY2025 | Aug 8, 2025 | $0.17 | $0.20 | +17.6% | $0.29B | $0.30B | -3.5% |
| ▲ Q2 FY2025 | May 1, 2025 | $0.12 | $0.14 | +16.7% | $0.25B | $0.28B | -8.1% |
| — Q1 FY2025 | Feb 27, 2025 | $0.21 | $0.21 | +0.0% | $0.29B | $0.26B | +11.8% |
| ▼ Q4 FY2024 | Nov 5, 2024 | $0.19 | $0.17 | -10.5% | $0.29B | $0.29B | -2.2% |
Q3 FY2026
Aug 6, 2026
EPS Actual
—
EPS Est.
$0.24
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 5, 2026Beat
EPS Actual
$0.18
EPS Est.
$0.17
EPS Surpr.
+5.9%
Revenue
$0.28B
Q1 FY2026
Feb 24, 2026Beat
EPS Actual
$0.26
EPS Est.
$0.24
EPS Surpr.
+8.3%
Revenue
$0.30B
Q4 FY2025
Nov 4, 2025Beat
EPS Actual
$0.26
EPS Est.
$0.22
EPS Surpr.
+18.2%
Revenue
$0.31B
Q3 FY2025
Aug 8, 2025Beat
EPS Actual
$0.20
EPS Est.
$0.17
EPS Surpr.
+17.6%
Revenue
$0.29B
Q2 FY2025
May 1, 2025Beat
EPS Actual
$0.14
EPS Est.
$0.12
EPS Surpr.
+16.7%
Revenue
$0.25B
Q1 FY2025
Feb 27, 2025
EPS Actual
$0.21
EPS Est.
$0.21
EPS Surpr.
+0.0%
Revenue
$0.29B
Q4 FY2024
Nov 5, 2024Miss
EPS Actual
$0.17
EPS Est.
$0.19
EPS Surpr.
-10.5%
Revenue
$0.29B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.30 | $0.31 | $0.31 | 2 |
| Q3 FY2027 | $0.29 | $0.29 | $0.30 | 2 |
| Q2 FY2027 | $0.26 | $0.26 | $0.27 | 2 |
| Q1 FY2027 | $0.20 | $0.21 | $0.21 | 2 |
| Q4 FY2026 | $0.27 | $0.28 | $0.28 | 4 |
| Q3 FY2026 | $0.27 | $0.27 | $0.28 | 6 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.3B | $0.3B | $0.4B | 3 |
| Q3 FY2027 | $0.3B | $0.3B | $0.3B | 3 |
| Q2 FY2027 | $0.3B | $0.3B | $0.3B | 3 |
| Q1 FY2027 | $0.3B | $0.3B | $0.3B | 3 |
| Q4 FY2026 | $0.3B | $0.3B | $0.3B | 5 |
| Q3 FY2026 | $0.3B | $0.3B | $0.3B | 6 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 5, 2026 | +5.9% | $15.39 | $15.33 | -0.39% |
| ▲ Q1 FY2026 | Feb 24, 2026 | +8.3% | $17.49 | $16.72 | -4.40% |
| ▲ Q4 FY2025 | Nov 4, 2025 | +18.2% | $16.61 | $16.43 | -1.08% |
| ▲ Q3 FY2025 | Aug 8, 2025 | +17.6% | $11.22 | $13.97 | +24.51% |
| ▲ Q2 FY2025 | May 1, 2025 | +16.7% | $11.50 | $12.10 | +5.22% |
| ▲ Q1 FY2025 | Feb 27, 2025 | +0.0% | $13.64 | $12.28 | -9.97% |
| ▼ Q4 FY2024 | Nov 5, 2024 | -10.5% | $15.80 | $15.42 | -2.41% |
| ▲ Q3 FY2024 | Aug 5, 2024 | +11.8% | $13.22 | $14.22 | +7.56% |
Q2 FY2026-0.39%
Report Date
May 5, 2026
EPS Beat/Miss
+5.9%
Price Before
$15.39
Price After
$15.33
Q1 FY2026-4.40%
Report Date
Feb 24, 2026
EPS Beat/Miss
+8.3%
Price Before
$17.49
Price After
$16.72
Q4 FY2025-1.08%
Report Date
Nov 4, 2025
EPS Beat/Miss
+18.2%
Price Before
$16.61
Price After
$16.43
Q3 FY2025+24.51%
Report Date
Aug 8, 2025
EPS Beat/Miss
+17.6%
Price Before
$11.22
Price After
$13.97
Q2 FY2025+5.22%
Report Date
May 1, 2025
EPS Beat/Miss
+16.7%
Price Before
$11.50
Price After
$12.10
Q1 FY2025-9.97%
Report Date
Feb 27, 2025
EPS Beat/Miss
+0.0%
Price Before
$13.64
Price After
$12.28
Q4 FY2024-2.41%
Report Date
Nov 5, 2024
EPS Beat/Miss
-10.5%
Price Before
$15.80
Price After
$15.42
Q3 FY2024+7.56%
Report Date
Aug 5, 2024
EPS Beat/Miss
+11.8%
Price Before
$13.22
Price After
$14.22
Avg Beat Reaction+3.06%
Avg Miss Reaction-2.41%
Beat Rate7 / 8 quarters
Largest Move+24.51% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SHC ends December
Sotera Health Company (SHC) most recently reported earnings on May 5, 2026 for Q2 FY2026, posting EPS of $0.18 — beating the analyst consensus of $0.17 by +5.9%. SHC has beaten EPS estimates for 6 consecutive quarters. The next SHC earnings date is expected around September 1, 2026.
Each quarter, investors track SHC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SHC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SHC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SHC earnings · 5 questionsSotera Health Company's next earnings report is expected around September 1, 2026. SHC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SHC historically reports after market close (AMC).
SHC earnings datewhen is SHC earningsSHC next earnings datewhen does SHC report earningsSHC earnings calendar
▸ Source: FMP · Sotera Health Company SEC filings · US GAAP · Sotera Health Company SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026